Epidemiology of community-associated Clostridium difficile infection, 2009 through 2011

JAMA Internal Medicine

Volumn 173, Issue 14, 2013, Pages 1359-1367

  Chitnis, Amit S ^a,b   Holzbauer, Stacy M ^b   Belflower, Ruth M ^a,c   Winston, Lisa G ^d   Bamberg, Wendy M ^e   Lyons, Carol ^f   Farley, Monica M ^g,h   Dumyati, Ghinwa K ⁱ   Wilson, Lucy E ^j   Beldavs, Zintars G ^k   Dunn, John R ^l   Gould, L Hannah ^a   MacCannell, Duncan R ^a   Gerding, Dale N ^m,n   McDonald, L Clifford ^a   Lessa, Fernanda C ^a  

^a NATIONAL CENTER FOR EMERGING AND ZOONOTIC INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c ATLANTA RESEARCH AND EDUCATION FOUNDATION   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e San Francisco School of Medicine ^*  (United States)

^f YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h ATLANTA VA MEDICAL CENTER   (United States)

ⁱ UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^j MARYLAND DEPARTMENT OF HEALTH AND MENTAL HYGIENE   (United States)

^k OREGON HEALTH AUTHORITY   (United States)

^l TENNESSEE DEPARTMENT OF HEALTH   (United States)

^m LOYOLA UNIVERSITY CHICAGO   (United States)

ⁿ HINES VA HOSPITAL   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; CEPHALOSPORIN DERIVATIVE; CLINDAMYCIN; FOLIC ACID INHIBITOR; MACROLIDE; PENICILLIN DERIVATIVE; PROTON PUMP INHIBITOR; QUINOLONE DERIVATIVE; TETRACYCLINE DERIVATIVE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CHILD; CLOSTRIDIUM DIFFICILE INFECTION; COMMUNICABLE DISEASE; DISEASE SURVEILLANCE; DRUG EXPOSURE; FEMALE; HOUSEHOLD; HUMAN; INFANT; INTERVIEW; MAJOR CLINICAL STUDY; MALE; OUTPATIENT; OUTPATIENT CARE; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; UNITED STATES;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; ANTI-BACTERIAL AGENTS; CHILD; CHILD, PRESCHOOL; CLOSTRIDIUM DIFFICILE; COMMUNITY-ACQUIRED INFECTIONS; DRUG UTILIZATION; ELECTROPHORESIS, GEL, PULSED-FIELD; ENTEROCOLITIS, PSEUDOMEMBRANOUS; FECES; FEMALE; HISTAMINE H2 ANTAGONISTS; HOSPITALIZATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFANT; MALE; MIDDLE AGED; MOLECULAR TYPING; MULTIVARIATE ANALYSIS; POPULATION SURVEILLANCE; PROTON PUMP INHIBITORS; UNITED STATES; YOUNG ADULT;

EID: 84880691277     PISSN: 21686106     EISSN: None     Source Type: Journal    
DOI: 10.1001/jamainternmed.2013.7056     Document Type: Article

References (43)

1. Barbut F, Corthier G, Charpak Y, et al. Prevalence and pathogenicity of Clostridium difficile in hospitalized patients: a French multicenter study. Arch Intern Med. 1996;156(13):1449-1454.
2. Bartlett JG. Historical perspectives on studies of Clostridium difficile and C. difficile infection. Clin Infect Dis. 2008;46(suppl 1):S4-S11.
3. Centers for Disease Control and Prevention (CDC). Severe Clostridium difficile-associated disease in populations previously at low risk: four states, 2005. MMWR Morb Mortal Wkly Rep. 2005;54(47):1201-1205.
4. Centers for Disease Control and Prevention (CDC). Surveillance for community-associated Clostridium difficile: Connecticut, 2006. MMWR Morb Mortal Wkly Rep. 2008;57(13):340-343.
5. Kutty PK,WoodsCW, Sena AC, et al. Risk factors for and estimated incidence of communityassociated Clostridium difficile infection, North Carolina, USA. Emerg Infect Dis. 2010;16(2):197-204.
6. Kuntz JL, Chrischilles EA, Pendergast JF, Herwaldt LA, Polgreen PM. Incidence of and risk factors for community-associated Clostridium difficile infection: a nested case-control study. BMC Infect Dis. 2011;11:194. http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3154181/. Accessed April 27, 2013.
7. Karlstrom O, Fryklund B, Tullus K, Burman LG. A prospective nationwide study of Clostridium difficile-associated diarrhea in Sweden: the Swedish C. difficile Study Group. Clin Infect Dis. 1998;26(1):141-145.
8. Wilcox MH, Mooney L, Bendall R, Settle CD, Fawley WN. A case-control study of community-associated Clostridium difficile infection. J Antimicrob Chemother. 2008;62(2): 388-396.
9. RupnikM,Wilcox MH, Gerding DN. Clostridium difficile infection: new developments in epidemiology and pathogenesis. Nat RevMicrobiol. 2009;7(7):526-536.
10. Centers for Disease Control and Prevention. Measuring the scope of Clostridium difficile infection in the United States. http://www.cdc.gov/hai/ eip/clostridium-difficile.html. AccessedMay 21, 2012.
11. Charlson M, Szatrowski TP, Peterson J, Gold J. Validation of a combined comorbidity index. J Clin Epidemiol. 1994;47(11):1245-1251.
12. Arroyo LG, Rousseau J, Willey BM, et al. Use of a selective enrichment broth to recover Clostridium difficile from stool swabs stored under different conditions. J Clin Microbiol. 2005;43(10): 5341-5343.
13. Killgore G, Thompson A, Johnson S, et al. Comparison of seven techniques for typing international epidemic strains of Clostridium difficile: restriction endonuclease analysis, pulsed-field gel electrophoresis, PCR-ribotyping, multilocus sequence typing, multilocus variable-number tandem-repeat analysis, amplified fragment length polymorphism, and surface layer protein A gene sequence typing. J Clin Microbiol. 2008;46(2):431-437.
14. McDonald LC, Coignard B, Dubberke E, Song X, Horan T, Kutty PK; Ad Hoc Clostridium difficile SurveillanceWorking Group. Recommendations for surveillance of Clostridium difficile-associated disease. Infect Control Hosp Epidemiol. 2007;28(2): 140-145.
15. Stone S, Gonzales R, Maselli J, Lowenstein SR. Antibiotic prescribing for patients with colds, upper respiratory tract infections, and bronchitis: a national study of hospital-based emergency departments. Ann Emerg Med. 2000;36(4): 320-327.
16. Thorpe JM, Smith SR, Trygstad TK. Trends in emergency department antibiotic prescribing for acute respiratory tract infections. Ann Pharmacother. 2004;38(6):928-935.
17. Roumie CL, Halasa NB, Grijalva CG, et al. Trends in antibiotic prescribing for adults in the United States: 1995 to 2002. J Gen Intern Med. 2005;20(8):697-702.
18. Fischer T, Singer AJ, Lee C, Thode HC Jr. National trends in emergency department antibiotic prescribing for children with acute otitis media, 1996 2005. Acad Emerg Med. 2007;14(12): 1172-1175.
19. Grijalva CG, Nuorti JP, Griffin MR. Antibiotic prescription rates for acute respiratory tract infections in US ambulatory settings. JAMA. 2009;302(7):758-766.
20. Shapiro DJ, Gonzales R, Cabana MD, Hersh AL. National trends in visit rates and antibiotic prescribing for children with acute sinusitis. Pediatrics. 2011;127(1):28-34.
21. WilsonW, Taubert KA, Gewitz M, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research InterdisciplinaryWorking Group. Circulation. 2007;116(15):1736-1754.
22. Valiquette L, Cossette B, Garant MP, Diab H, Pepin J. Impact of a reduction in the use of high-risk antibiotics on the course of an epidemic of Clostridium difficile-associated disease caused by the hypervirulent NAP1/027 strain. Clin Infect Dis. 2007;45(suppl 2):S112-S121.
23. TalpaertMJ, Gopal Rao G, Cooper BS,Wade P. Impact of guidelines and enhanced antibiotic stewardship on reducing broad-spectrum antibiotic usage and its effect on incidence of Clostridium difficile infection. J Antimicrob Chemother. 2011;66(9):2168-2174.
24. Bartlett JG, Chang TW, Gurwith M, Gorbach SL, Onderdonk AB. Antibiotic-associated pseudomembranous colitis due to toxin-producing clostridia. N Engl J Med. 1978;298(10):531-534.
25. Falsen E, Kaijser B, Nehls L, Nygren B, Svedhem A. Clostridium difficile in relation to enteric bacterial pathogens. J Clin Microbiol. 1980;12(3):297-300.
26. Hirschhorn LR, Trnka Y, Onderdonk A, LeeML, Platt R. Epidemiology of community-acquired Clostridium difficile-associated diarrhea. J Infect Dis. 1994;169(1):127-133.
27. Riley TV, Cooper M, Bell B, Golledge CL. Community-acquired Clostridium difficile-associated diarrhea. Clin Infect Dis. 1995;20(suppl 2):S263-S265.
28. Deshpande A, Pant C, Pasupuleti V, et al. Association between proton pump inhibitor therapy and Clostridium difficile infection in a meta-analysis. Clin Gastroenterol Hepatol. 2012;10(3):225-233.
29. Dial S, Delaney JA, Barkun AN, Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA. 2005;294(23): 2989-2995.
30. U.S. Food and Drug Administration. FDA Drug Safety Communication: Clostridium difficile-associated diarrhea can be associatedwith stomach acid drugs known as proton pump inhibitors (PPIs). http://www.fda.gov/Drugs/ DrugSafety/ucm290510.htm. AccessedMay 21, 2012.
31. Stevens V, Dumyati G, Brown J,Wijngaarden E. Differential risk of Clostridium difficile infection with proton pump inhibitor use by level of antibiotic exposure. Pharmacoepidemiol Drug Saf. 2011;20(10):1035-1042.
32. Shaughnessy MK, Micielli RL, DePestel DD, et al. Evaluation of hospital room assignment and acquisition of Clostridium difficile infection. Infect Control Hosp Epidemiol. 2011;32(3):201-206.
33. Bolton RP, Tait SK, Dear PR, Losowsky MS. Asymptomatic neonatal colonisation by Clostridium difficile. Arch Dis Child. 1984;59(5):466-472.
34. Tullus K, Aronsson B, Marcus S, Mollby R. Intestinal colonization with Clostridium difficile in infants up to 18 months of age. Eur J Clin Microbiol Infect Dis. 1989;8(5):390-393.
35. Matsuki S, Ozaki E, Shozu M, et al. Colonization by Clostridium difficile of neonates in a hospital, and infants and children in three day-care facilities of Kanazawa, Japan. Int Microbiol. 2005;8(1): 43-48.
36. Kim K, DuPont HL, Pickering LK. Outbreaks of diarrhea associated with Clostridium difficile and its toxin in day-care centers: evidence of person-to-person spread. J Pediatr. 1983;102(3): 376-382.
37. Pepin J, Gonzales M, Valiquette L. Risk of secondary cases of Clostridium difficile infection among household contacts of index cases. J Infect. 2012;64(4):387-390.
38. Gould LH, Limbago B. Clostridium difficile in food and domestic animals: a new foodborne pathogen? Clin Infect Dis. 2010;51(5):577-582.
39. Harvey RB, Norman KN, Andrews K, et al. Clostridium difficile in retail meat and processing plants in Texas. J Vet Diagn Invest. 2011;23(4): 807-811.
40. Curry SR, Marsh JW, Schlackman JL, Harrison LH. Prevalence of Clostridium difficile in uncooked ground meat products from Pittsburgh, Pennsylvania. Appl EnvironMicrobiol. 2012;78(12): 4183-4186.
41. Limbago B, Thompson AD, Greene SA, et al. Development of a consensus method for culture of Clostridium difficile from meat and its use in a survey of U.S. retail meats. Food Microbiol. 2012;32(2):448-451.
42. Harvey RB, Norman KN, Andrews K, et al. Clostridium difficile in poultry and poultry meat. Foodborne Pathog Dis. 2011;8(12): 1321-1323.
43. Cerniglia CE, Kotarski S. Approaches in the safety evaluations of veterinary antimicrobial agents in food to determine the effects on the human intestinal microflora. J Vet Pharmacol Ther. 2005;28(1):3-20.